Balaji Amines Limited · NSE:BALAMINES
Balaji Amines — Investor Presentation (2019)
23 slides from Balaji Amines's investor presentation, 2019
Slide 1: Investor Presentation
if be | AMINES LIMITED INVESTOR PRESENTATION
Slide 2: Disclaimer
Disclaimer This Presentation and the accompanying slides (the “Presentation”), which have been prepared by Balaji Amines Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securiti
Slide 3: Business Overview and Future Outlook
Business Overview and Future Outlook
Slide 4: Business Overview and Future Outlook
Business Overview and Future Outlook Balaji Amines Ltd., INDIA, an ISO 9001: 2015 certified company, specialised in manufacturing Methylamines, Ethylamines, Derivatives of Specialty Chemicals. These have been the main products, we also have facilities for the manufacture of derivatives, which are Ke
Slide 5: Business Overview and Future Outlook
Business Overview and Future Outlook BAL for the first time in India tested on an indigenously developed technology and developed it further over a period of time. Today, BAL‘s products are accepted in international markets and have gained the distinct export quality status, which makes it one of th
Slide 6: Business Overview and Future Outlook
Business Overview and Future Outlook
Slide 7: Balaji Speciality Chemicals Pvt Ltd
BALAJI SPECIALITY CHEMICALS PVT LTD Balaji Speciality Chemicals Pvt Ltd (BSCPL) was incorporated in the year 2010 and involved in various R&D activities in developing processes for some of the Specialty chemicals. BSCPL became subsidiary of Balaji Amines Limited in 2018 by virtue of Investment of 55
Slide 8: Research & Developments
RESEARCH & DEVELOPMENTS BAL has in-house R&D centre recognised by the Department of Science and Technology, Government of India. BAL has been carrying out continuous Research and Development in the following areas recently: • Identification of new products and development of latest process technolog
Slide 9: Research & Developments
RESEARCH & DEVELOPMENTS • Adoption of advanced technologies in recovering waste heat, waste water has resulted in minimizing the impact on environment and concentration of core principle of Reduce, Reuse and Recycle of all the resources. • For sustainable usage of natural resources, the Company has
Slide 10: Market Leadership
Market Leadership - Methyl Amines & Derivatives : Market Share of > 60% in India - Di-Methyl Amine Hydrochloride (DMA-HCL) : nearly 60 to 70% of the global market share - The only manufacturer in India of NMP, NEP, Morpholine, 2-P, GBL, PVPK, DMF - Most of our product selections are import substitut
Slide 11: Usage
Usage BAL caters to the industries which are considered to be important for growth of the economy, it includes : Active Pharmaceuticals Ingredients (APIs) Agro –chemicals and pesticide formulations Refineries Water treatment chemicals Rubber Chemicals Electronics sector Leather processing chemicals
Slide 12: Key Milestones
Key Milestones FY - 88 - Inception of Balaji Amines Limited to manufacturing Methyl Amines and Later added Ethyl Amines to the range FY - 91 - First Plant Commissioned for Manufacturing Aliphatic Amines at Tamalwadi, Solapur (Unit I) FY - 92 - Developed its own in-house R&D center to manufacture few
Slide 13: Key Milestones
Key Milestones FY - 01 - BAL became ISO 9001 certified Company FY - 03 - Second Expansion of DMAHCL Plant at Unit II - Increased the Manufacturing capacity of Mythyl Amines FY - 05 - Developed few more Speciality products like NMP, Morpholine at in-house R&D center FY - 06 - Became first and sole ma
Slide 14: Key Milestones
Key Milestones FY - 10 - Started PVP-K30 (Polyvinyl Pyrrolidone) plant - Started Dimethyl Amino Ethanol (DMAE) plant FY - 11 - Started GBL, NMP/2P FY - 12 - Expanded Methylamines plant FY - 13 - Started Dimethyl Formamide for the First time and Expanded Dimethyl Amine Hydrochloride FY - 14 - Started
Slide 15: Key Milestones
Key Milestones FY - 18 - Allotment of 90 Acres of Land at MIDC, Chincholi and the Maharashtra state Government has accorded “Mega Project” Status for this new Project - new plant for manufacture of Morpholine and Acetonitrile is commissioned after successful trial runs and ready to be operational -
Slide 16: Standalone Profit & Loss
Standalone Profit & Loss (Rs. In Lakhs) Sl. Particulars Quarter ended Nine months ended Year ended No. 31.12.2018 30.09.2018 31.12.2017 31.12.2018 31.12.2017 31.03.2018 1 Total Income from Operations 24085.81 21787.11 21940.39 71989.10 62288.35 88104.73 2 Net Profit before Tax, Exceptional and/or Ex
Slide 17: Key Financial Highlights
Key Financial Highlights Net Sales (in Lacs) 1,00,000.00 90,000.00 80,000.00 70,000.00 60,000.00 50,000.00 86364.74 40,000.00 66753.42 61012.63 63492.35 30,000.00 60486.18 51179.6 44952.36 20,000.00 35709.56 26189.58 10,000.00 0.00 2009-10 2010-11 2011-12 2012-13 2013-14 2014-15 2015-16 2016-17 2017
Slide 18: Key Financial Highlights
Key Financial Highlights PAT (in Lacs) 12,000.00 10,000.00 8,000.00 6,000.00 11318.1 8557.32 4,000.00 6127.06 2,000.00 3566.17 3352.27 3635.82 3118.35 2661.36 2064.95 0.00 2009-10 2010-11 2011-12 2012-13 2013-14 2014-15 2015-16 2016-17 2017-18 2018-19 PAT (in Lacs)
Slide 19: Key Financial Highlights
Key Financial Highlights PBT (in Lacs) 18,000.00 16,000.00 14,000.00 12,000.00 10,000.00 8,000.00 16583.84 13048.45 6,000.00 9315.44 4,000.00 5274.07 5574.06 2,000.00 4297.78 4595.6 4564.31 3156.45 0.00 2009-10 2010-11 2011-12 2012-13 2013-14 2014-15 2015-16 2016-17 2017-18 2018-19 PBT (in Lacs)
Slide 20: Key Financial Highlights
Key Financial Highlights EBIDTA (in Lacs) 25,000.00 20,000.00 15,000.00 10,000.00 19416.64 16039.13 13113.65 5,000.00 10574.69 9361.85 8350.03 8392.63 6479.7 4774.24 0.00 2009-10 2010-11 2011-12 2012-13 2013-14 2014-15 2015-16 2016-17 2017-18 2018-19 EBITDA (in Lacs)
Slide 21: Key Financial Highlights
Key Financial Highlights ROCE (in %) 35.00 30.00 25.00 20.00 15.00 31.05 27.12 27.98 23.683 24.47 22.17 22.98 10.00 19.13 18.08 5.00 0.00 2009-10 2010-11 2011-12 2012-13 2013-14 2014-15 2015-16 2016-17 2017-18 2018-19 ROCE (in %)
Slide 22: Key Financial Highlights
Key Financial Highlights ROE (in %) 30.00 25.00 20.00 15.00 24.39 24.23 22.68 10.00 21 18.67 19.09 18.08 16.58 15.3 5.00 0.00 2009-10 2010-11 2011-12 2012-13 2013-14 2014-15 2015-16 2016-17 2017-18 2018-19 ROE (in %)
Slide 23: Thank you!